Cocrystal Pharma, Inc. logo

Cocrystal Pharma, Inc.

NASDAQ:COCP

Overview | Financials
Company Name Cocrystal Pharma, Inc.
Symbol COCP
Currency USD
Price 1.7
Market Cap 17,295,460
Dividend Yield 0%
52-week-range 1.33 - 3.1
Industry Biotechnology
Sector Healthcare
CEO Dr. Sam Lee Ph.D.
Website https://www.cocrystalpharma.com

An error occurred while fetching data.

About Cocrystal Pharma, Inc.

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside

Related Stocks

Applied Therapeutics, Inc. logo

Applied Therapeutics, Inc.

APLT

5.7 USD

Moleculin Biotech, Inc. logo

Moleculin Biotech, Inc.

MBRX

2.4 USD

Evogene Ltd. logo

Evogene Ltd.

EVGN

2.96 USD

Spero Therapeutics, Inc. logo

Spero Therapeutics, Inc.

SPRO

1.315 USD

IN8bio, Inc. logo

IN8bio, Inc.

INAB

0.304 USD

Neoleukin Therapeutics, Inc. logo

Neoleukin Therapeutics, Inc.

NLTX

3.49 USD

Financials

Numbers are in millions USD

Numbers are in millions USD